Sutro Biopharma, Inc. (FRA:S09)
Germany · Delayed Price · Currency is EUR 0.7625
+0.0210 (2.83%)
Last updated: Dec 1, 2025, 9:59 AM CET
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of €58.7 million as of December 1, 2025. Its market cap has decreased by -81.38% in one year.
Market Cap
58.70M
Enterprise Value
-70.28M
Revenue
90.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.76
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from 297.24M to 58.70M, a decrease of -80.25%. That is a compound annual growth rate of -20.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 67.50M | -53.94% |
| Dec 31, 2024 | 146.55M | -38.05% |
| Dec 29, 2023 | 236.57M | -45.56% |
| Dec 30, 2022 | 434.54M | -28.22% |
| Dec 31, 2021 | 605.40M | -25.04% |
| Dec 31, 2020 | 807.60M | 256.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |